Form 8-K - Current report:
SEC Accession No. 0000950170-24-130202
Filing Date
2024-11-22
Accepted
2024-11-22 16:08:26
Documents
13
Period of Report
2024-11-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K orgo-20241118.htm   iXBRL 8-K 51658
2 EX-99.1 orgo-ex99_1.htm EX-99.1 10649
3 GRAPHIC img36819578_0.jpg GRAPHIC 631
  Complete submission text file 0000950170-24-130202.txt   183020

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT orgo-20241118.xsd EX-101.SCH 29636
16 EXTRACTED XBRL INSTANCE DOCUMENT orgo-20241118_htm.xml XML 4518
Mailing Address 85 DAN ROAD CANTON MA 02021
Business Address 85 DAN ROAD CANTON MA 02021 781-575-0775
Organogenesis Holdings Inc. (Filer) CIK: 0001661181 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37906 | Film No.: 241489785
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)